Circadian Signatures in Chronic Lung Disease
慢性肺病的昼夜节律特征
基本信息
- 批准号:10221776
- 负责人:
- 金额:$ 62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAirway DiseaseAirway ResistanceAlpha RhythmAnimal ModelAntiviral ResponseAsthmaAtlasesBackBiologyBrain DeathCellsCharacteristicsChronicChronic DiseaseChronic Obstructive Airway DiseaseChronic lung diseaseChronotherapyCircadian RhythmsClinicalCustomCytometryDangerousnessDataDependenceDeteriorationDiseaseDonor personEpithelial CellsExhibitsGene ExpressionGene Expression ProfileGenesGoalsHospitalizationHumanIndividualInfluenza A virusInfluenza preventionKnowledgeLeadLeukocyte TraffickingLifeLungLung diseasesModelingMolecularMusOrganOrgan ProcurementsOrgan TransplantationPathogenesisPathologicPathologyPatient CarePatientsPatternPeriodicityPeripheralPhenotypePhysiologyPredispositionPublic HealthQuality of lifeRegulationReporterResearchRiskSamplingTherapeuticTimeTissuesTranslatingTransplantationViralVirusVirus Diseasesairway epitheliumairway remodelingantimicrobialasthma modelasthmaticbasebronchial epitheliumcellular imagingcircadiancircadian pacemakercircadian regulationfightingimprovedin vivoin vivo imagingindividual patientmolecular clockmouse modelnew therapeutic targetnovel markerpathogenprecision medicinepreventprogramsrepositoryrespiratory virusresponsetraffickingtraittranscriptomeuser-friendlyweb-accessible
项目摘要
PROJECT SUMMARY/ABSTRACT
Circadian rhythms are an important yet poorly understood feature of chronic lower respiratory disease. In airway
diseases such as asthma and chronic obstructive pulmonary disease (COPD), nocturnal exacerbations are a
disease-defining characteristic in which normal circadian swings in airway resistance are pathologically
amplified. Circadian rhythms are generated by a cell-autonomous molecular clock that orchestrates tissue-
specific rhythms in gene expression, leading to oscillations in physiology including in the lung. Research
suggests that molecular clock function specifically within airway epithelial cells regulates innate antimicrobial
responses. Such responses are critical in chronic lung disease because they may determine whether an
encounter with a virus or other pathogen triggers a clinical exacerbation. Currently, there is no information on
the circadian regulatory program within the human lung and how chronic disease might rewrite this regulation to
drive pathogenesis. Here we show that chronic lung disease alters rhythms in circadian clock gene expression
in human bronchial epithelial cells (HBECs) from patients. We demonstrate that HBECs express circadian
transcriptomes encompassing hundreds of genes and exhibit disease-specific patterns that can be further altered
by acute viral infection. As such, we hypothesize that chronic airway disease reprograms circadian gene
expression in airway cells thereby influencing virus susceptibility. The overarching goal of this project is to
translate circadian biology into disease-modifying treatments for patients with chronic airway disease by
mitigating or preventing virally triggered clinical exacerbations. Aim 1: Identify disease-specific circadian
gene expression programs regulating antiviral responses in asthma and COPD patients. Using a unique
repository of HBECs developed by our group that were isolated from human lung explants, we will determine the
circadian transcriptomes of HBECs obtained from asthma and COPD patients and compare these to donors
without chronic airway disease. In parallel, we will phenotype HBECs in terms of their susceptibility to acute
influenza A virus (IAV) infection in the presence or absence of circadian clock disruption. Observations in HBECs
will be backed by single cell imaging of circadian rhythms and a first-of-its-kind analysis of in vivo human airway
circadian gene expression using serial airway brushing samples obtained from organ transplant donors after
brain death while they await organ procurement. Aim 2: Discover evolutionarily conserved circadian
reprogramming in chronic airway disease. We will use a well characterized mouse model of asthma/COPD-
like airway remodeling with known clock regulation of antiviral responses. Using this model, we will examine lung
circadian reprogramming of gene expression and leukocyte trafficking by chronic airway disease and determine
the dependency of this program on the airway epithelial cell peripheral clock. These studies will be backed by
in vivo imaging of airway clock gene expression in mice using bioluminescent reporters.
项目摘要/摘要
昼夜节律是慢性下呼吸道疾病的一个重要但知之甚少的特征。在呼吸道中
如哮喘和慢性阻塞性肺疾病(COPD)等疾病,夜间加重是一种
疾病定义的特征,即呼吸道阻力的正常昼夜波动是病理性的
放大了。昼夜节律是由一个细胞自主的分子时钟产生的,它协调组织-
基因表达的特定节律,导致包括肺在内的生理振荡。研究
提示分子钟在呼吸道上皮细胞中的特异性作用调节先天抗菌药物
回应。这种反应在慢性肺部疾病中至关重要,因为它们可能决定
遇到病毒或其他病原体会引发临床恶化。目前,还没有关于
人体肺内的昼夜节律程序以及慢性疾病可能如何重写这一规则以
驱使病机。在这里,我们展示了慢性肺部疾病改变了生物钟基因表达的节律。
在患者的人支气管上皮细胞(HBECs)中。我们证明HBECs表达昼夜节律
转录本包含数百个基因,并显示出可以进一步改变的疾病特异性模式
由急性病毒感染引起。因此,我们假设慢性呼吸道疾病改变了昼夜节律基因。
在呼吸道细胞中的表达,从而影响病毒的敏感性。这个项目的首要目标是
通过以下方式将昼夜生物学转化为慢性呼吸道疾病患者的疾病修正治疗
减轻或预防病毒引发的临床恶化。目标1:确定特定疾病的昼夜节律
调节哮喘和慢性阻塞性肺病患者抗病毒反应的基因表达程序。使用唯一的
我们小组开发的从人肺外植体中分离的HBECs的库,我们将确定
哮喘和慢性阻塞性肺疾病患者HBECs的昼夜转录本及其与供者的比较
没有慢性呼吸道疾病。同时,我们将根据HBECs对急性胰腺炎的易感性进行表型分析。
甲型流感病毒(IAV)感染时存在或不存在生物钟干扰。HBECs中的观测
将得到昼夜节律的单细胞成像和对活体人类呼吸道的首个此类分析的支持
器官移植供者术后连续呼吸道刷检标本的昼夜节律基因表达
他们在等待器官购买时脑死亡。目标2:发现进化保守的昼夜节律
慢性呼吸道疾病的重新编程。我们将使用一种具有良好特性的哮喘/慢性阻塞性肺病小鼠模型-
就像已知的抗病毒反应的时钟调节的呼吸道重塑。利用这个模型,我们将检查肺部
慢性呼吸道疾病基因表达和白细胞转运的昼夜节律重编程
这一程序对呼吸道上皮细胞外周时钟的依赖性。这些研究将得到以下支持
使用生物发光报告器对小鼠呼吸道时钟基因表达的活体成像。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Adam Haspel其他文献
Jeffrey Adam Haspel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Adam Haspel', 18)}}的其他基金
Clock Gene Control of Viral Infection and Asthma
病毒感染和哮喘的时钟基因控制
- 批准号:
10064005 - 财政年份:2016
- 资助金额:
$ 62万 - 项目类别:
Role of Macroautophagy and Circadian Clock Disruption in Sepsis Pathogenesis
巨自噬和昼夜节律紊乱在脓毒症发病机制中的作用
- 批准号:
8913997 - 财政年份:2012
- 资助金额:
$ 62万 - 项目类别:
Role of Macroautophagy and Circadian Clock Disruption in Sepsis Pathogenesis
巨自噬和昼夜节律紊乱在脓毒症发病机制中的作用
- 批准号:
8538470 - 财政年份:2012
- 资助金额:
$ 62万 - 项目类别:
Role of Macroautophagy and Circadian Clock Disruption in Sepsis Pathogenesis
巨自噬和昼夜节律紊乱在脓毒症发病机制中的作用
- 批准号:
8353262 - 财政年份:2012
- 资助金额:
$ 62万 - 项目类别:
Role of Macroautophagy and Circadian Clock Disruption in Sepsis Pathogenesis
巨自噬和昼夜节律紊乱在脓毒症发病机制中的作用
- 批准号:
8721440 - 财政年份:2012
- 资助金额:
$ 62万 - 项目类别:
相似海外基金
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
- 批准号:
10744673 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
- 批准号:
10723956 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
- 批准号:
10733573 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
- 批准号:
10733607 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Immune Mediators of IL-22 Signaling Alter Allergic Airway Disease
IL-22 信号的免疫介质改变过敏性气道疾病
- 批准号:
10853347 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应
- 批准号:
10722599 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10985906 - 财政年份:2023
- 资助金额:
$ 62万 - 项目类别:
Mentoring patient-oriented researchers in inflammatory airway disease
指导炎症性气道疾病领域以患者为中心的研究人员
- 批准号:
10657746 - 财政年份:2022
- 资助金额:
$ 62万 - 项目类别: